特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

フェムテック (Femtech) の世界市場 - 分析と予測:2019-2030年

Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030

発行 BIS Research Inc. 商品コード 941003
出版日 ページ情報 英文 203 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.61円で換算しております。
フェムテック (Femtech) の世界市場 - 分析と予測:2019-2030年 Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030
出版日: 2020年06月06日 ページ情報: 英文 203 Pages
担当者のコメント
2020年6月出版の「フェムテック (Femtech) の世界市場 - 分析と予測:2019-2030年」は、国別でのフェムテック市場の規模を把握できます。ALYK、Inc. 、NaturalCycles Nordic AB 、他19社分のプレーヤープロフィールが載ってあり、レポートの感じを細かく確認したい方に対し、オンラインデモで原本のご案内が可能ですので、是非お申し込み下さい。
概要

世界のフェムテック (Femtech)市場規模は、2019年時点で8億2060万米ドルと推計され、予測期間中は12.65%の成長が見込まれています。市場の主な推進要因の1つは、女性における感染症および慢性疾患の発生率の増加であり、効果的でより個別化された治療の需要が急増しています。さらに、近年、女性の健康意識は大幅に高まっています。

当レポートでは、世界のフェムテック (Femtech) 市場について取り上げ、市場ダイナミクス、競合環境、各セグメント・地域別の市場、競合状況、および主要企業などについて詳細に分析しています。

第1章 製品の定義

第2章 調査範囲

第3章 調査手法

  • 1次データソース
  • 2次データソース
  • 市場予測モデル
  • 調査対象企業
  • 前提条件と制限事項

第4章 産業分析

  • 業界動向
    • 意思決定者としての女性の過小評価
    • 価格とブランド戦略
    • 新興国のフェムテック
    • 総合的な女性のヘルスケアの重要性の高まり
    • スマート医療機器とウェアラブル
    • 月経と更年期障害は恥ずべきことではない
  • フェムテックのイノベーショントラッカー
    • 妊孕性トラッキングのためのウェアラブルデバイス
    • 生殖周期モニタリングのための膣センサー
    • ジェノミクスとビッグデータを活用した妊孕性トラッキングと月経健康
    • 乳がん検診用ウェアラブル
  • 規制の枠組み
    • 北米の規制の枠組み
    • 欧州の規制枠組み
  • 資金分析
    • フェムテックは過去5年間で10億米ドル以上を獲得
    • フェムテックにおける注目の民間資金

第5章 競合情勢

  • 主な発展と戦略
    • 資金
    • コラボレーションとパートナーシップ
    • 製品の発売とアップグレード
    • 合併と買収
  • ビジネスモデル分析
    • ワンフォーワンギブバックモデル
    • 直販
    • サブスクリプション
    • 処方薬テレメディスンモデル
  • 製品マッピング分析

第6章 市場力学

  • 市場成長促進要因
    • 技術の領域における女性の認識の高まり
    • 女性の健康による経済的負担は5,000億米ドルを超える
    • ウェアラブルデバイスの爆発的増加と女性の間でスマートフォンの普及率が増加
  • 市場成長抑制要因
    • 女性の意思決定者が不足
    • 女性の健康問題を取り巻く社会的タブー
    • 農村地域における女性の意識の欠如
    • 業界の主張を裏付ける科学的研究の欠如
    • 資本と労働力の調達
    • フェムテック領域における製品マーケティング
  • 市場機会
    • 妊産婦、出生前および新生児のケアのための製品開発への投資
    • サハラ以南のアフリカへの投資
    • 更年期障害管理のための製品開発

第7章 世界のフェムテック市場

  • 前提条件と制限事項
  • 主な調査結果と機会の評価
    • 主な調査結果
    • 市場機会の評価

第8章 世界のフェムテック市場(コンポーネント別)

  • 概要
  • モバイルアプリ
  • コネクテッドデバイス
    • ウェアラブルコネクテッドデバイス
    • 非ウェアラブルコネクテッドデバイス
  • サービス
  • その他(オーガニック、スマートな女性用衛生用品)

第9章 世界のフェムテック市場(アプリケーション別)

  • 概要
  • リプロダクティブヘルス
    • 周期トラッキング
    • 家庭における妊孕性トラッキング・モニタリング
  • 一般的なウェルネス
  • 妊娠と介護
    • 妊娠中のケア
    • 妊娠後のケア
    • 母乳育児
    • その他
  • 骨盤と子宮のケア
    • 骨盤ウェルネス
    • 月経健康

第10章 世界のフェムテック市場(エンドユーザー)

  • 概要
  • 個人
  • 不妊治療クリニック
  • 病院・研究機関
  • 診断センター

第11章 世界のフェムテック市場(地域別)

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • スウェーデン
    • スペイン
    • フランス
    • オランダ
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • インド
    • その他
  • 中東、南アフリカ、 ラテンアメリカ
    • 中東
    • 南アフリカ
    • ラテンアメリカ
    • その他

第12章 企業プロファイル

  • 概要
  • ALYK、Inc.
  • Aytu BioScience、Inc.
  • Biowink GmbH
  • Bloomlife
  • CORA
  • Flo Health、Inc.
  • Glow, Inc.
  • Inne
  • Kasha
  • NaturalCycles Nordic AB
  • Ovia Health
  • Plackal Tech
  • Sustain Natural
  • The Flex Company
  • Thinx、Inc.
  • 企業スナップショット
    • Celmatix Inc.
    • Conceivable Inc.
    • Lia Diagnostics Inc.
    • Lucina Health、Inc.( Unified Women's Healthcare, LLCの子会社)
    • Progny, Inc.
    • Univfy Inc.
図表

List of Tables

  • Table 1: Some of the largest rounds of funding received by Femtech companies in 2019 include:
  • Table 2: Global Femtech Market (by End User), $Million, 2019-2030
  • Table 4.1: Pricing and Branding Strategy in the Global Femtech Market
  • Table 4.2: Celmatix, Inc: Product Portfolio
  • Table 4.3: Regulatory Framework for Femtech Market in North America
  • Table 4.4: Regulatory Framework for Femtech Market in Europe
  • Table 4.5: Venture Capital Firms for Women Health
  • Table 4.6: Private Funding in Global Femtech Market, 2019
  • Table 5.1: Global Femtech Market, Products
  • Table 6.1: Prevalence of Diseases in Women, 2017
  • Table 6.2: Global Mobile Phone Adoption by Women
  • Table 8.1: Mobile Applications for Women Reproductive Health
  • Table 8.1: Femtech Integration in Fertility Treatment
  • Table 9.1: Competitive Analysis
  • Table 9.2: Leading Products
  • Table 9.3: The size of healthcare burden of certain conditions that can be attributed to Menopause
  • Table 9.4: Wearables for Pregnancy Care
  • Table 9.5: Leading Solutions Developed by Healthcare Organizations for Gestational Diabetes Mellitus (GDM) Monitoring
  • Table 9.6: Salient Features of Freely Available Mobile Apps That Help Women to Ease into Postpartum
  • Table 10.1: Privacy Policy Analysis
  • Table 11.1: Breakdown of Funding Under National Women's Health Strategy 2020-2030
  • Table 11.2: Other Innovative Femtech Start-Ups in Israel

List of Figures

  • Figure 1: Global Female Income to Reach $26 Trillion by the End of 2020
  • Figure 2: Average Health Spending by Age and Gender, 2016
  • Figure 3: Global Femtech Market, $Million, 2018-2030
  • Figure 4: Global Femtech Market (by Component Type), Percent Share (%), 2019 and 2030
  • Figure 5: Global Femtech Market (by Region), $Million, 2019, 2025 and 2030
  • Figure 2.1: Global Femtech Market Segmentation
  • Figure 3.1: Global Femtech Market Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: Venture Capital Firms Deal Count, 2008-2018
  • Figure 5.1: Share of Key Developments and Strategies, January 2016-March 2020
  • Figure 5.2: Funding Activity Share (by Company), January 2016-March 2020
  • Figure 5.3: Collaborations and Partnerships Share (by Company), January 2016-March 2020
  • Figure 5.4: Product Launches (by Company), January 2016-March 2020
  • Figure 5.5: Mergers and Acquisitions (by Company), January 2016- March 2020
  • Figure 5.6: Global Femtech Market, Product Mapping Analysis, 2019
  • Figure 6.1: Women Health Expenditure in the U.S., $Million, 2016-2020
  • Figure 6.2: Global Wearable Device Adoption by Women, 2018
  • Figure 8.1: Global Femtech Market (by Component)
  • Figure 8.2: Global Femtech Market (Apps), 2018-2030
  • Figure 8.3: Workflow in a Period Tracking Application
  • Figure 8.4: Global Femtech Market (Connected Devices), 2018-2030
  • Figure 8.5: Global Femtech Market (Services), 2018-2030
  • Figure 8.6: Global Femtech Market (Others), 2018-2030
  • Figure 9.1: Global Femtech Market (by Application)
  • Figure 9.2: Global Femtech Market (Reproductive Health), 2018-2030
  • Figure 9.3: Global Femtech Market (General Wellness), 2018-2030
  • Figure 9.4: Global Femtech Market (Pregnancy and Nursing Care), 2018-2030
  • Figure 9.5: Global Femtech Market (Pelvic and Uterine Care), 2018-2030
  • Figure 10.1: Global Femtech Market ( Individual Users), 2018-2030
  • Figure 10.2: Global Femtech Market (Fertility Clinics), 2018-2030
  • Figure 10.3: Global Femtech Market (Hospitals and Research Institutes), 2018-2030
  • Figure 10.4: Global Femtech Market (Diagnostic Centers), 2018-2030
  • Figure 11.1: Global Femtech Market (by Region)
  • Figure 11.2: North America Femtech Market, 2018-2030
  • Figure 11.3: North America: Market Dynamics
  • Figure 11.4: U.S. Femtech Market, 2018-2030
  • Figure 11.5: Canada Femtech Market, 2018-2030
  • Figure 11.6: Europe Femtech Market, 2018-2030
  • Figure 11.7: Europe: Market Dynamics
  • Figure 11.8: Germany Femtech Market, 2018-2030
  • Figure 11.9: U.K. Femtech Market, 2018-2030
  • Figure 11.10: Sweden Femtech Market, 2018-2030
  • Figure 11.11: Spain Femtech Market, 2018-2030
  • Figure 11.12: France Femtech Market, 2018-2030
  • Figure 11.13: Netherlands Femtech Market, 2018-2030
  • Figure 11.14: Rest-of-Europe Femtech Market, 2018-2030
  • Figure 11.15: Asia-Pacific Femtech Market, 2018-2030
  • Figure 11.16: Asia-Pacific: Market Dynamics
  • Figure 11.17: China Femtech Market, 2018-2030
  • Figure 11.18: Japan Femtech Market, 2018-2030
  • Figure 11.19: South Korea Femtech Market, 2018-2030
  • Figure 11.20: Australia Femtech Market, 2018-2030
  • Figure 11.21: India Femtech Market, 2018-2030
  • Figure 11.22: Rest-of-Asia-Pacific Femtech Market, 2018-2030
  • Figure 11.23: Rest-of-the-World Femtech Market, 2018-2030
  • Figure 11.24: Middle East, Africa, and Latin America: Market Dynamics
  • Figure 11.25: Israel Femtech Market, 2018-2030
  • Figure 11.26: Saudi Arabia Femtech Market, 2018-2030
  • Figure 11.27: UAE Femtech Market, 2018-2030
  • Figure 11.28: South Africa Femtech Market, 2018-2030
  • Figure 11.29: Brazil Femtech Market, 2018-2030
  • Figure 11.30: Mexico Femtech Market, 2018-2030
  • Figure 11.31: Rest-of-RoW Femtech Market, 2018-2030
  • Figure 12.1: ALYK, Inc.: Product Portfolio for the Global Femtech Market
  • Figure 12.2: ALYK,Inc.: SWOT Analysis
  • Figure 12.3: Aytu Bioscience, Inc.: Product Portfolio for Global Femtech Market
  • Figure 12.4: Aytu Bioscience: Overall Financials, 2016-2018
  • Figure 12.5: Aytu Bioscience, Inc. Revenue (by Region), 2017-2018
  • Figure 12.6: Aytu Bioscience, Inc. R&D Expenditure, 2016-2018
  • Figure 12.7: Aytu Bioscience, Inc: SWOT Analysis
  • Figure 12.8: Biowink GmbH: Product Portfolio for the Global Femtech Market
  • Figure 12.9: Biowink GmbH.: SWOT Analysis
  • Figure 12.10: Bloomlife: Product Portfolio for the Global Femtech Market
  • Figure 12.11: Bloomlife.: SWOT Analysis
  • Figure 12.12: CORA.: Product Portfolio for the Global Femtech Market
  • Figure 12.13: CORA SWOT Analysis
  • Figure 12.14: Flo Health Inc.: Product Portfolio for the Global Femtech Market
  • Figure 12.15: Flo Health Inc.: SWOT Analysis
  • Figure 12.16: Glow, Inc.: Product Portfolio for the Global Femtech Market
  • Figure 12.17: Glow, Inc.: SWOT Analysis
  • Figure 12.18: Inne.: Product Portfolio for the Global Femtech Market
  • Figure 12.19: Inne. SWOT Analysis
  • Figure 12.20: Kasha.: Product Portfolio for the Global Femtech Market
  • Figure 12.21: Kasha SWOT Analysis
  • Figure 12.22: NaturalCycles Nordic AB.: Product Portfolio for the Global Femtech Market
  • Figure 12.23: NaturalCycels Nordic AB: SWOT Analysis
  • Figure 12.24: Ovia Health.: Product Portfolio for the Global Femtech Market
  • Figure 12.25: Ovia Health: SWOT Analysis
  • Figure 12.26: Plackal Tech: Product Portfolio for the Global Femtech Market
  • Figure 12.27: Plackal Tech.: SWOT Analysis
  • Figure 12.28: Sustain Natural.: Product Portfolio for the Global Femtech Market
  • Figure 12.29: Sustain Natural SWOT Analysis
  • Figure 12.30: The Flex Company.: Product Portfolio for the Global Femtech Market
  • Figure 12.31: The Flex Company SWOT Analysis
  • Figure 12.32: Thinx Inc..: Product Portfolio for the Global Femtech Market
  • Figure 12.33: Thinx Inc. SWOT Analysis
目次
Product Code: BH207A

“Global Femtech Market to Reach $3.04 Billion by 2030.”

Market Segmentation

  • Component - Mobile Apps, Connected Devices, Services, Others
  • Application - Reproductive Health, Pregnancy and Nursing Care, Pelvic and Uterine Health, General Health and Wellness
  • End Users- Individuals, Hospitals, Diagnostic Centers, and Fertility Clinics

Regional Segmentation

  • North America - U.S., Canada
  • Europe -Germany, U.K., France, Spain, Netherlands, Sweden, Switzerland, Belgium
  • Asia-Pacific - China, Japan, India, South Korea, and Australia
  • Rest-of-the-World - Saudi Arabia, United Arab Emirates, Israel, South Africa, Brazil and Mexico

Growth Drivers

  • Growing recognition of Women in the Domain of Technology
  • Economic Burden of Women's health is more than $500 Billion
  • Explosion of wearable devices and increasing smartphone penetration among women

Market Challenges

  • Lack of women decision makers
  • Societal taboos surrounding women's health issues
  • Absence of awareness among women in rural areas
  • Lack of scientific studies to back industrial claims

Market Opportunities

  • Investment in product development for maternal, pre- and neo-natal care
  • Investment in sub-Saharan Africa
  • Product development for menopause management

Key Companies Profiled

ALYK, Inc., Aytu BioScience, Inc., Biowink GmbH, CORA, Flo Health, Inc., Bloomlife, Glow, Inc., Inne, Kasha, NaturalCycles Nordic AB, Plackal Tech, Ovia Health, Sustain Natural, The Flex Company, Thinx, Inc., Celmatix Inc., Conceivable Inc., Lia Diagnostics Inc., Lucina Health, Inc., Progny, Inc., Univfy Inc., among others

Key Questions Answered:

  • How has the market evolved in the last five years, and what are the awaited technological advancements in the field of Femtech?
  • What are the major market drivers, challenges, and opportunities in the global Femtech market?
  • What are the underlying structures resulting in the emerging trends within the Femtech industry?
  • What was the market value of the leading segments of the global Femtech market in 2019?
  • What are the influencing factors that may affect the market positioning of the key players?
  • How is industry expected to evolve during the forecast period 2019-2030?
  • What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
  • What are the key business models employed by the femtech companies to standout in the evolving market?
  • What is the growth potential of Femtech in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
  • What are the key regulatory implications in developed and developing regions for Femtech?
  • What was the funding trends for the Femtech companies in the last three years and how would the funding scenario change during the forecast period?

Market Overview

Despite having huge potential, the Femtech industry is still immensely underfunded accounting for only 1.4% aggregated capital that flows into healthcare. Also, a large number of healthcare venture capitalists are yet to invest in this sector. Indeed, the amount of investment received by the Femtech industry is on a rise but at a surprisingly slow pace considering the potential of the market.

However, the signs of future growth are also quite evident. Five years ago, the amount of funding received by this sector had barely reached about $100 million. The Femtech industry witnessed more than $500 million funding (till 2019). The number of women centric start-ups have significantly multiplied in the recent years. This surge is also primarily attributed to the launch of fertility tracking app by PayPal co-founder Max Levchin in 2013. The app also witnessed high profile VC funding from agencies such as Andreessen Horowitz and Founders Fund.

Today, a large number of start-ups could be seen in the market offering fertility tracking apps, as well as those focused on egg freezing and fertility treatments, women-centric clinical care and even subscription-based tampons. Some of the top-tier VCs have also entered this field. For example, Kleiner Perkins, has backed a fertility platform called Progyny with a funding of $49 million, while NEA has backed a sexual wellness start-up called Nuelle offering a financial support of $23 million.

As of 2019, the global Femtech market was estimated to be $820.6 million and is anticipated to grow with a double digit CAGR of 12.65% during the forecast period. One of the major driving factor for the market is increasing incidence of infectious and chronic diseases among the female population leading to surge in demand for effective and more personalized treatment. Furthermore, women's health awareness has significantly increased in recent years. For an instance, it was not until 2004, the cardiovascular diseases were considered medically a threat to women's health. However, campaigns such as the American Heart Association's Go Red for Women campaign and the NHLBI's Heart Truth program have significantly boosted the awareness related to life threatening diseases such as CVD.

Another reason driving the growth of the market is growing prevalence of infectious disease among females in low to middle-income countries due to an unhygienic environment. For an instance, in 2013, 60% of new HIV infections in population younger than 25 years occurred in girls and young women. Also, untreated syphilis in low- and middle-income countries still causes over 200 000 deaths every year.

However, some of the major challenges restraining the growth of the market are: creation of awareness among women, particularly in rural areas, unequal distribution of women as compared to men in investment community, and lack of understanding of women health issues by investors, among others.

Competitive Landscape

The Femtech market comprises over 200 start-ups worldwide, 92 percent of which are founded and led by women. Big names in these areas are developing entirely new solutions such as the Flex Disc, Thinx absorbent period underwear, or the Glow fertility and ovulation tracker. While others focus on building tech platforms and subscription services to make existing products such as birth control and period products more easily accessible.

Although majority of Femtech firms are focusing on the millennials, there are also companies working for women at all ages. For example, Genneve, an online clinic aimed at aiding women entering menopause. Also, other companies such as Madorra and MenoGeni are developing devices and pharmaceutical alternatives to aid in the treatment of menopausal symptoms. Companies are extensively entering new women's health spaces to stand out in the competition. Some of the emerging women's heath spaces are osteoporosis, breast cancer, autoimmune conditions, stroke, thyroid issues, chronic fatigue, anxiety, and depression.

Table of Contents

Executive Summary

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Scope of the Study

  • 2.1 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Primary Data Sources
  • 3.2 Secondary Data Sources
  • 3.3 Market Estimation Model
  • 3.4 Companies Profiled
  • 3.5 Assumptions and Limitations

4 Industry Analysis

  • 4.1 Industry Trends
    • 4.1.1 Underrepresentation of Women as Decision Makers
    • 4.1.2 Pricing and Branding Strategies
    • 4.1.3 Femtech in Emerging Economies
    • 4.1.4 Growing Emphasis on Holistic Women Healthcare
    • 4.1.5 Smart Medical Devices and Wearables
    • 4.1.6 Destigmatizing Menstrual Health and Menopause
  • 4.2 Femtech Innovation Tracker
    • 4.2.1 Wearable Devices for Fertility Tracking
    • 4.2.2 Vaginal Sensor for Fertility Cycle Monitoring
    • 4.2.3 Leveraging Genomics and Big Data for Fertility Tracking and Menstrual Health
    • 4.2.4 Wearables for Breast Cancer Screening
  • 4.3 Regulatory Framework
    • 4.3.1 Regulatory Framework in North America
    • 4.3.2 Regulatory Framework in Europe
  • 4.4 Funding Analysis
    • 4.4.1 Femtech Received More Than $1 Billion Over the Last 5 Years
    • 4.4.2 Notable Private Funding in Femtech

5 Competitive Landscape

  • 5.1 Key Developments and Strategies
    • 5.1.1 Funding
    • 5.1.2 Collaborations and Partnerships
    • 5.1.3 Product Launch and Upgradation
    • 5.1.4 Mergers and Acquisitions
  • 5.2 Business Model Analysis
    • 5.2.1 One-for-One Give Back Model
    • 5.2.2 Direct-to-Consumer
    • 5.2.3 Subscription
    • 5.2.4 Prescription Telemedicine Model
  • 5.3 Product Mapping Analysis

6 Market Dynamics

  • 6.1 Market Drivers
    • 6.1.1 Growing Recognition of Women in the Domain of Technology
    • 6.1.2 Economic Burden by Women's Health is More Than $500 Billion
    • 6.1.3 Explosion of Wearable Devices and Increasing Smartphone Penetration Among Women
  • 6.2 Market Restraints
    • 6.2.1 Lack of Women Decision Makers
    • 6.2.2 Societal Taboos Surrounding Women's Health Issues
    • 6.2.3 Absence of Awareness Among Women in Rural Areas
    • 6.2.4 Lack of Scientific Studies to Back Industrial Claims
    • 6.2.5 Raising Capital and Workforce
    • 6.2.6 Product Marketing in Femtech Space
  • 6.3 Market Opportunities
    • 6.3.1 Investment in Product Development for Maternal, Pre- and Neo-Natal Care
    • 6.3.2 Investment in Sub-Saharan Africa
    • 6.3.3 Product Development for Menopause Management

7 Global Femtech Market

  • 7.1 Assumptions and Limitations
  • 7.2 Key Findings and Opportunity Assessment
    • 7.2.1 Key Findings
    • 7.2.2 Opportunity Assessment

8 Global Femtech Market (by Component)

  • 8.1 Overview
  • 8.2 Mobile Apps
  • 8.3 Connected Devices
    • 8.3.1 Wearable Connected Device
    • 8.3.2 Non-Wearable Connected Device
  • 8.4 Services
  • 8.5 Others (Organic, Smart Female Hygiene Products)

9 Global Femtech Market (by Application)

  • 9.1 Overview
  • 9.2 Reproductive Health
    • 9.2.1 Period Tracking
    • 9.2.2 At-Home Fertility Tracking and Monitoring
  • 9.3 General Wellness
      • 9.3.1.1 Menopause
  • 9.4 Pregnancy and Nursing Care
    • 9.4.1 Pregnancy Care
    • 9.4.2 Post Pregnancy Care
      • 9.4.2.1 Post-Partum Depression
    • 9.4.3 Breastfeeding
    • 9.4.4 Others
  • 9.5 Pelvic and Uterine Care
    • 9.5.1 Pelvic Wellness
    • 9.5.2 Menstrual Health

10 Global Femtech Market (by End User)

  • 10.1 Overview
  • 10.2 Individuals
  • 10.3 Fertility Clinics
  • 10.4 Hospitals and Research Institutes
  • 10.5 Diagnostic Centers

11 Global Femtech Market (By Region)

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 U.K.
    • 11.3.3 Sweden
    • 11.3.4 Spain
    • 11.3.5 France
    • 11.3.6 Netherlands
    • 11.3.7 Rest-of-Europe
      • 11.3.7.1 Switzerland
      • 11.3.7.2 Belgium
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 South Korea
    • 11.4.4 Australia
    • 11.4.5 India
    • 11.4.6 Rest-of-Asia-Pacific
      • 11.4.6.1 New Zealand
  • 11.5 Middle East, South Africa, and Latin America
    • 11.5.1 Middle East
      • 11.5.1.1 Israel
      • 11.5.1.2 Saudi Arabia
      • 11.5.1.3 UAE
    • 11.5.2 South Africa
    • 11.5.3 Latin America
      • 11.5.3.1 Brazil
      • 11.5.3.2 Mexico
    • 11.5.4 Rest-of-Rest -of-the-World (Rest-of-RoW)

12 Company Profiles

  • 12.1 Overview
  • 12.2 ALYK, Inc.
    • 12.2.1 Company Overview
    • 12.2.2 Role of ALYK, Inc. in the Global Femtech Market
    • 12.2.3 Recent Developments
    • 12.2.4 SWOT Analysis: ALYK, Inc.
  • 12.3 Aytu BioScience, Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Role of Aytu Bioscience, Inc. in the Global Femtech Market
    • 12.3.3 Financials
    • 12.3.4 Key Insights About Financial Health of the Company
    • 12.3.5 Recent Developments
    • 12.3.6 SWOT Analysis
  • 12.4 Biowink GmbH
    • 12.4.1 Company Overview
    • 12.4.2 Role of Biowink GmbH in the Global Femtech Market
    • 12.4.3 Recent Developments
    • 12.4.4 SWOT Analysis: Biowink GmbH
  • 12.5 Bloomlife
    • 12.5.1 Company Overview
    • 12.5.2 Role of Bloomlife GmbH in the Global Femtech Market
    • 12.5.3 Recent Developments
    • 12.5.4 SWOT Analysis: Bloomlife
  • 12.6 CORA
    • 12.6.1 Company Overview
    • 12.6.2 Role of CORA in the Global Femtech Market
    • 12.6.3 Recent Developments
    • 12.6.4 SWOT Analysis: CORA
  • 12.7 Flo Health, Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Role of Flo Health Inc. in the Global Femtech Market
    • 12.7.3 Recent Developments
    • 12.7.4 SWOT Analysis: Flo Health Inc.
  • 12.8 Glow, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Role of Glow, Inc. in the Global Femtech Market
    • 12.8.3 Recent Developments
    • 12.8.4 SWOT Analysis: Glow, Inc.
  • 12.9 Inne
    • 12.9.1 Company Overview
    • 12.9.2 Role of Inne in the Global Femtech Market
    • 12.9.3 Recent Developments
    • 12.9.4 SWOT Analysis: Inne.
  • 12.10 Kasha
    • 12.10.1 Company Overview
    • 12.10.2 Role of Kasha in the Global Femtech Market
    • 12.10.3 Recent Developments
    • 12.10.4 SWOT Analysis: Kasha
  • 12.11 NaturalCycles Nordic AB
    • 12.11.1 Company Overview
    • 12.11.2 Role of NaturalCycles Nordic AB in the Global Femtech Market
    • 12.11.3 Recent Developments
    • 12.11.4 SWOT Analysis: NaturalCycels Nordic AB
  • 12.12 Ovia Health
    • 12.12.1 Company Overview
    • 12.12.2 Role of Ovia Health Inc. in the Global Femtech Market
    • 12.12.3 Recent Developments
    • 12.12.4 SWOT Analysis: Ovia Health
  • 12.13 Plackal Tech
    • 12.13.1 Company Overview
    • 12.13.2 Role of Plackal Tech in the Global Femtech Market
    • 12.13.3 Recent Developments
    • 12.13.4 SWOT Analysis: Plackal Tech.
  • 12.14 Sustain Natural
    • 12.14.1 Company Overview
    • 12.14.2 Role of Sustain Natural in the Global Femtech Market
    • 12.14.3 Recent Developments
    • 12.14.4 SWOT Analysis: Sustain Natural
  • 12.15 The Flex Company
    • 12.15.1 Company Overview
    • 12.15.2 Role of The Flex Company in the Global Femtech Market
    • 12.15.3 Recent Developments
    • 12.15.4 SWOT Analysis: The Flex Company
  • 12.16 Thinx, Inc.
    • 12.16.1 Company Overview
    • 12.16.2 Role of Thinx Inc. in the Global Femtech Market
    • 12.16.3 Recent Developments
    • 12.16.4 SWOT Analysis: Thinx Inc.
  • 12.17 Company Snapshots
    • 12.17.1 Celmatix Inc.
      • 12.17.1.1 Company Overview
      • 12.17.1.2 Role of Celmatix Inc. in the Global Femtech Market
    • 12.17.2 Conceivable Inc.
      • 12.17.2.1 Company Overview
      • 12.17.2.2 Role of Conceivable Inc. in the Global Femtech Market
    • 12.17.3 Lia Diagnostics Inc.
      • 12.17.3.1 Company Overview
      • 12.17.3.2 Role of Lia Diagnostics Inc. in the Global Femtech Market
    • 12.17.4 Lucina Health, Inc. (Subsidiary of Unified Women's Healthcare, LLC)
      • 12.17.4.1 Company Overview
      • 12.17.4.2 Role of Lucina Health, Inc. in the Global Femtech Market
    • 12.17.5 Progny, Inc.
      • 12.17.5.1 Company Overview
      • 12.17.5.2 Role of Progny, Inc. in the Global Femtech Market
    • 12.17.6 Univfy Inc.
      • 12.17.6.1 Company Overview
      • 12.17.6.2 Role of Univfy Inc. in the Global Femtech Market